The important regulatory role of androgens on the TMPRSS2:ETS fusion via interaction with the androgen receptor (AR) enables a new promise for a potential role of the gene fusions in predicting the emergence of castration resistant prostate cancer (CRPC). The gene discussed is TMPRSS2; the disease is Familial prostate cancer.